Finance

Lists
Why is HIMS up ၁၀.၁၉%?
Dive Deeper
HIMS:NYSE
Hims & Hers Health Inc
၃၀.၉၂ US$
+၁၀.၁၉%
(+၂.၈၆) 1D
၃၀.၉၃ US$
+၀.၀၃% (+၀.၀၁၀)
After hours
Closed: အောက် ၉, GMT-၄ ၁၆:၀၀:၀၇  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HIMS...
Open
၂၈.၃၄ US$
High
၃၁.၄၅ US$
Low
၂၈.၃၁ US$
Mkt. cap
၇၂၁.၄၀ ဋေ
Avg. vol.
၉.၆၃ သန်း
Volume
၁.၆၀ ကုဋေ
52-wk high
၆၅.၃၀ US$
52-wk low
၁၃.၇၄ US$
EPS
-၀.၆၃ US$
Beta
၂.၄၄
Shares outstanding
၂၂.၄၉ ကုဋေ
No. of employees
၂ ထောင်
Open
၂၈.၃၄ US$
High
၃၁.၄၅ US$
Low
၂၈.၃၁ US$
Mkt. cap
၇၂၁.၄၀ ဋေ
Avg. vol.
၉.၆၃ သန်း
Volume
၁.၆၀ ကုဋေ
52-wk high
၆၅.၃၀ US$
52-wk low
၁၃.၇၄ US$
EPS
-၀.၆၃ US$
Beta
၂.၄၄
Shares outstanding
၂၂.၄၉ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
CryptoRank
CryptoRank
·
ပြီးခဲ့သည့် ၂၃ နာရီ
Hims & Hers Health, Inc. Tokenized Stock (Coinbase)
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁ ရက်
Hims Shares Have The Bull Case Changed After Privacy And Billing Lawsuits
TipRanks
TipRanks
·
ပြီးခဲ့သည့် ၂ ရက်
Bullish Options Bets Send Hims & Hers Shares Higher
Profile
Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model. Wikipedia
About Hims & Hers Health Inc
CEO-
Employees၂.၄၄ ထောင်
Foundedနို ၂၀၁၇
Headquartersဆန်ဖရန်စစ္စကိုမြို့, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth care provider
Websitehims.com
Analyst ratings
Based on 14 analysts giving stock ratings to HIMS in the past 3 months
Hold
Buy
3
Hold
11
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for HIMS in the last 3 months.
Highest
Current ၃၀.၉၂ US$
၄၂.၀၀ US$ (+၃၅.၈၃%)
Average
၃၂.၈၂ US$ (+၆.၁၄%)
Lowest
၂၆.၀၀ US$ (-၁၅.၉၁%)
Analyst
Recommendation
Action
Price target
Projected
Date
Allen Lutz
Bank of America Securities
Hold
Maintained
၃၂.၀၀ US$
+၃.၅%
10/08/2026
Jailendra Singh
Truist Financial
Hold
Reiterated
၃၂.၀၀ US$
+၃.၅%
09/11/2026
Bryan Smilek
J.P. Morgan
Hold
Initiated
၃၂.၀၀ US$
+၃.၅%
09/11/2026
Brian Tanquilut
Jefferies
Hold
Maintained
၃၁.၀၀ US$
+၀.၃%
09/03/2026
Justin Patterson
KeyBanc
Hold
Maintained
-
-
09/02/2026
Glen Santangelo
Barclays
Buy
Reiterated
၃၅.၀၀ US$
+၁၃.၂%
08/20/2026
George Hill
Deutsche Bank
Hold
Reiterated
၂၆.၀၀ US$
-၁၅.၉%
08/11/2026
Jonna Kim
TD Cowen
Hold
Reiterated
၃၀.၀၀ US$
-၃%
08/11/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
၂၈.၀၀ US$
-၉.၄%
08/11/2026
Maria Ripps
Canaccord Genuity
Buy
Reiterated
၄၀.၀၀ US$
+၂၉.၄%
08/11/2026
Ryan MacDonald
Needham
Buy
Reiterated
၄၂.၀၀ US$
+၃၅.၈%
08/11/2026
David Larsen
BTIG
Hold
Reiterated
-
-
08/11/2026
Daniel Grosslight
Citi
Hold
Maintained
၃၃.၀၀ US$
+၆.၇%
08/12/2026
Mark Mahaney
Evercore ISI
Hold
Maintained
-
-
08/11/2026
Oliver Chen
TD Cowen
Hold
Reiterated
၂၅.၀၀ US$
-၁၉.၁%
05/12/2026
Cory Carpenter
J.P. Morgan
Buy
Maintained
၃၃.၀၀ US$
+၆.၇%
05/12/2026
Michael Cherny
Leerink Partners
Hold
Maintained
-
-
04/16/2026
Unknown Analyst
Nephron
Buy
Upgraded
၃၅.၀၀ US$
+၁၃.၂%
03/09/2026
Last report
၂၀၂၆ ဩ ၁၀
Fiscal period
Q2 2026
-၀.၀၉ US$ / ၀.၀၉ US$
-၁၉၈.၂၂%miss
Revenue / Est. (USD)
၇၅.၃၂ ကုဋေ / ၇၃.၀၁ ကုဋေ
+၃.၁၆%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၅၉.၉၀ ကုဋေ
၆၁.၇၈ ကုဋေ
၆၀.၈၁ ကုဋေ
၇၅.၃၂ ကုဋေ
Cost of goods sold
၁၅.၆၉ ကုဋေ
၁၇.၃၄ ကုဋေ
၁၈.၂၈ ကုဋေ
၂၇.၂၄ ကုဋေ
Cost of revenue
၁၅.၆၉ ကုဋေ
၁၇.၃၄ ကုဋေ
၁၈.၂၈ ကုဋေ
၂၇.၂၄ ကုဋေ
Research and development expenses
၄.၀၆ ကုဋေ
၄.၁၀ ကုဋေ
၄.၆၉ ကုဋေ
၅.၄၉ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃၈.၉၇ ကုဋေ
၃၈.၆၆ ကုဋေ
၄၂.၆၄ ကုဋေ
၅၂.၁၉ ကုဋေ
Operating expense
၄၃.၀၃ ကုဋေ
၄၂.၇၆ ကုဋေ
၄၇.၃၃ ကုဋေ
၅၇.၆၈ ကုဋေ
Total operating expenses
၅၈.၇၂ ကုဋေ
၆၀.၁၀ ကုဋေ
၆၅.၆၁ ကုဋေ
၈၄.၉၃ ကုဋေ
Operating income
၁.၁၈ ကုဋေ
၁.၆၈ ကုဋေ
-၄.၈၀ ကုဋေ
-၉.၆၀ ကုဋေ
Other non operating income
-၅.၉၉ သန်း
-၅.၇၅ သိန်း
-၁.၈၆ ကုဋေ
-၂.၄၃ သန်း
EBT including unusual items
၁.၂၂ ကုဋေ
၁.၈၄ ကုဋေ
-၁၀.၁၆ ကုဋေ
-၉.၂၆ ကုဋေ
EBT excluding unusual items
၁.၂၂ ကုဋေ
၂.၁၆ ကုဋေ
-၆.၁၆ ကုဋေ
-၉.၆၂ ကုဋေ
Income tax expense
-၃.၅၅ သန်း
-၂.၂၅ သန်း
-၉.၄၄ သန်း
-၆.၃၄ သန်း
Effective tax rate
-၂၉.၀၅%
-၁၂.၂၅%
၉.၂၉%
၆.၈၅%
Other operating expenses
-
-
-
-
Net income
၁.၅၈ ကုဋေ
၂.၀၆ ကုဋေ
-၉.၂၁ ကုဋေ
-၈.၆၃ ကုဋေ
Net profit margin
၂.၆၃%
၃.၃၃%
-၁၅.၁၅%
-၁၁.၄၆%
Earnings per share
၀.၂၈
၀.၂၂
-၀.၁၉
-၀.၀၉
Interest and investment income
၈.၀၁ သန်း
၆.၈၀ သန်း
၇.၉၀ သန်း
၆.၀၀ သန်း
Interest expense
-၁.၆၀ သန်း
-၁.၅၀ သန်း
-၂.၈၇ သန်း
-၃.၇၅ သန်း
Net interest expenses
၆.၄၁ သန်း
၅.၃၀ သန်း
၅.၀၃ သန်း
၂.၂၅ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
၂.၉၅ ကုဋေ
၃.၄၉ ကုဋေ
-၂.၆၁ ကုဋေ
-၆.၆၆ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ